HIF1A and breast cancer: Resveratrol analogue HS-1793 improves tumor tissue perfusion and hypoxia status under low oxygen conditions by inhibiting HIF-1α, suppressing angiogenesis, and enhancing radiosensitivity in mouse breast cancer cells (117).